Your session is about to expire
← Back to Search
Alpha-proteinase Inhibitor for Eosinophilic Esophagitis (ZEEPS Trial)
ZEEPS Trial Summary
This trial will study a drug to help people with Eosinophilic Esophagitis, a type of throat inflammation.
ZEEPS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 4 trial • 10 Patients • NCT03126370ZEEPS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have Crohn's, inflammatory bowel disease, or Celiac disease.I am taking blood thinners other than aspirin or NSAIDs.My esophagus has inflammation with more than 15 eosinophils per high powered field, not caused by another known condition.I have been diagnosed with COPD.I am between 18 and 70 years old.I do not have conditions like hypereosinophilic syndrome or parasitic infections affecting my esophagus.I tried standard treatments for EoE for about 8 weeks without success or couldn't tolerate them.I have a blood disorder that affects clotting.I can understand and agree to the study's procedures.My EoE or related condition treatment has been stable for the last 8 weeks.I currently have COVID-19.I've had moderate to severe chest or stomach pain or trouble swallowing more than twice a week in the last 2 weeks.I currently have an active H. pylori infection or have documentation of its eradication.
- Group 1: Active Drug
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this particular research endeavor welcome elderly participants?
"The target population for this study consist of adults aged 18 and above, but below 70 years old."
Has Active Drug been certified by the FDA?
"The safety of Active Drug was assessed as a 2 since this is in the early stages of development and no efficacy data has been collected yet, although some evidence does support its level of security."
What is the aggregate number of people joining this clinical trial?
"Indeed, the clinicaltrials.gov page for this medical research confirms that it is actively recruiting patients. The initial post was made on June 21st 2023 and more recent information has been supplied as of June 20th 23. This project requires 15 volunteers to be gathered from a single medical centre."
Are there vacancies for volunteers in this research endeavor?
"According to the clinicaltrials.gov portal, this medical trial is presently looking for participants and was initially posted on June 21st 2023 with its most recent edit occurring a day prior."
Is participation in this trial open to the public?
"This clinical trial is currently recruiting 15 individuals diagnosed with eosinophilic esophagitis aged 18 up to 70 years. Participants must have an understanding of the research process and be willing to adhere to all study visits, abide by a stable diet for 8 weeks before enrollment, demonstrate moderate-severe abdominal/chest pain or dysphagia at least 2 episodes per week in the last two weeks prior to screening along with histologically active EoE peak count ≥15eos/hpf without other causes for oesinphilia, and consistently maintain existing medications (including PPI's) dosage levels over the same time period."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger